Canaan Partners

Founded in 1987, Canaan Partners is a global venture capital firm based in Menlo Park, California. With over $5 billion under management, the firm invests in early-stage technology and healthcare companies worldwide.

Brent Ahrens

General Partner

Brenton Ahrens

General Partner - West Coast

Nandu Anilal

Investor

John Balen

General Partner

Joydeep Bhattacharyya

General Partner

Past deals in Series C

Nivoda

Series C in 2024
Founded in 2017, Nivoda operates a B2B online marketplace for buying and selling diamonds and jewelry. It simplifies global trade by offering an all-in-one solution for partners, ensuring reliable sourcing and competitive pricing.

Autobahn Therapeutics

Series C in 2024
Autobahn Therapeutics develops brain-targeting, small molecule therapies for central nervous system disorders. Its lead program ABX-002 is a thyroid hormone receptor beta agonist being developed as an adjunctive treatment for mood disorders, including major depressive disorder and bipolar depression. The company emphasizes precision tuning of CNS exposure, validated clinical and biologic targets, and biomarker-guided development across neuropsychiatry, neurodegeneration, and neuroinflammation to address high unmet medical needs and improve patient outcomes.

AgomAb Therapeutics

Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

Kepler Communications

Series C in 2023
Kepler Communications designs, develops, and operates satellite networks for global connectivity. It specializes in Low-Earth Orbit (LEO) satellites, PolarConnect for extreme environments, Global Data Service for large data transfers, and everywhereIOT for IoT devices. Serving industries such as maritime, natural resources, research, defense, and logistics.

Instrumental

Series C in 2022
Instrumental, Inc. specializes in developing software solutions that enhance the efficiency of assembly lines, enabling them to operate autonomously while adapting to various parts and processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to reduce costs associated with scrap and rework by allowing manufacturers to identify and resolve issues on their assembly lines. Instrumental's technology has been deployed in multiple global assembly lines at leading manufacturers, helping to prevent delays in development schedules and start production at higher yields. In addition to its software offerings, Instrumental also provides services related to high-performance computing, data storage, and business continuity, catering to both commercial and government sectors. The firm is headquartered in Saint Paul, Minnesota, and has been operational since 1991.

CompStak

Series C in 2021
CompStak, Inc., founded in 2011 and headquartered in New York, operates an online platform that provides a comprehensive database of commercial lease comparables. Utilizing a crowd-sourced model, CompStak facilitates the exchange of detailed lease information, which includes tenant names, addresses, rental rates, square footage, landlord concessions, broker identities, and other pertinent data. This information is critical for real estate investors, brokers, asset managers, and appraisers as they conduct valuations and analyses of commercial properties. CompStak's platform serves various stakeholders in the real estate market, enabling informed decision-making in significant investments and property comparisons. Additionally, CompStak has established a strategic partnership with Knowledge Cubed to enhance its data offerings, further solidifying its position in the industry.

Embroker

Series C in 2021
Embroker, Inc. is a digital insurance brokerage that specializes in providing insurance services to small and mid-sized businesses. Founded in 2015 and headquartered in San Francisco, with additional offices in Chicago, Boston, Denver, and New York, Embroker utilizes an online platform to streamline the process of purchasing, managing, and analyzing commercial insurance policies. The platform allows clients to automate the sharing, requesting, and tracking of proof of coverage, as well as monitor claims in real-time. Embroker offers a wide range of insurance products, including Commercial General Liability, property insurance, professional liability, and employee benefits, among others. The company also provides tools for peer comparison, enabling clients to benchmark their policies against industry standards. By combining technology with broker expertise, Embroker aims to enhance the efficiency and effectiveness of the $800 billion property and casualty insurance market, helping businesses save time and secure optimal coverage.

OncoResponse

Series C in 2021
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

Axis Security

Series C in 2021
Axis Security Inc. is a cybersecurity company founded in 2018 and based in Palo Alto, California. It specializes in Zero Trust Network Access solutions, providing a cloud security platform that ensures secure remote access to applications. The company's technology focuses on application isolation and employs a context-aware approach to security, evaluating multiple factors to ensure that only authorized users can access specific resources within a network. This business-centric strategy allows organizations to maintain control over sensitive information and manage access for employees, partners, and other stakeholders effectively.

Vivace Therapeutics

Series C in 2020
Founded in 2014, Vivace Therapeutics is a biotechnology company based in the San Francisco Bay Area. It focuses on discovering and developing cancer therapeutics by targeting novel pathways, with a particular emphasis on the Hippo pathway which controls tissue regeneration and organ size.

Dragos

Series C in 2020
Dragos is an industrial cybersecurity company dedicated to protecting the world's critical infrastructure. Its platform offers visibility into industrial control systems (ICS) and operational technology (OT) networks, enabling early threat detection and mitigation.

Vineti

Series C in 2020
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.

nTopology

Series C in 2020
nTopology, Inc. is an engineering software company founded in 2013 and headquartered in New York, New York. The company specializes in developing design software and tools aimed at optimizing manufacturing processes. Its flagship platform, nTopology, empowers engineers to create lightweight and optimized parts that meet specific functional requirements. The software includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, facilitating the integration of geometry and simulation data into manufacturing-ready models. By streamlining workflows and enhancing team collaboration, nTopology serves a diverse range of industries, including aerospace and defense, medical, automotive, consumer products, and education.

Mynd

Series C in 2020
Mynd is a tech-enabled property management firm specializing in single-family rental properties. It offers comprehensive solutions including marketing, tenant screening, rent collection, maintenance, accounting, and data-driven insights to optimize property performance and maximize returns for clients.

Ladder

Series C in 2020
Ladder is a digital life insurance company founded in 2015. It offers flexible term coverage up to $8M across all U.S. states, with an all-digital application process and real-time underwriting, aiming to make life insurance more accessible and affordable.

Vineti

Series C in 2020
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.

Astra

Series C in 2019
Astra Space, Inc. is a technology company based in Alameda, California, that specializes in designing and building rockets for satellite delivery and launch services. Founded in 2004 and originally known as Ventions LLC, the company rebranded in 2016 and aims to provide accessible and affordable access to space. Astra offers online reservations for payload deliveries to both sun-synchronous and low inclination orbits, with a focus on dedicated launch services for payloads ranging from 50 kg to 150 kg. The business is divided into two segments: Launch Services, which provides rapid global launch capabilities, and Space Products, which includes the development of space products tailored to customer needs for successful satellite launches. Astra operates test facilities to support its operations and is committed to facilitating frequent access to space for satellite operators and governments.

PerimeterX

Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

ScaleFactor

Series C in 2019
ScaleFactor provides automated accounting and finance software, offering features such as bookkeeping automation, proactive alerts, and business insights translation. It formerly offered additional services like IT integration, HR/payroll, compliance, and CFO advisory. ScaleFactor served various industries including professional services, restaurants, retail, technology, and wellness. The company was founded in 2014 and had offices across North America before ceasing operations.

MindTickle

Series C in 2019
MindTickle offers a sales readiness platform that enables companies to train, coach, and align their customer-facing teams. Its data-driven approach combines on-demand training, mobile updates, gamification, coaching, role-play, and assessment tools to enhance sales performance. Headquartered in San Francisco and Pune, MindTickle is privately held.

JOOR

Series C in 2019
JOOR operates a digital wholesale platform that connects fashion brands and retailers worldwide. The system replaces manual ordering with automated B2B order management, payment processing, and virtual showrooms, enabling faster transactions and reduced errors. It supplies data analytics to help users track performance, cut costs, and enhance customer experience. Through a curated network of global partners, the platform supports brands and buyers in building strategic relationships and scaling operations across markets.

PerimeterX

Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

Komprise

Series C in 2019
Komprise is a multi-cloud data management platform that enables organizations to analyze, move, and access file and object data across on-premises and cloud storage. It uses data growth analytics to identify hot and cold data and manages the data lifecycle across multiple storage vendors, including replication, archiving, and migration. The platform can relocate unstructured data to secondary storage based on criteria such as age, usage, or security to ensure data resides in the appropriate location at the right time. Founded in 2014 and headquartered in Campbell, California, Komprise focuses on intelligent data management to improve data accessibility and storage efficiency.

Contentsquare

Series C in 2019
ContentSquare is a digital experience insights optimization platform that helps businesses analyze customer behavior through vast amounts of anonymous web, mobile, and app interactions, adhering to data privacy regulations such as the EU GDPR and California CCPA. By integrating diverse data sets, including content, user experience, product offerings, pricing, acquisition channels, and technical performance, the platform generates insights and AI-driven recommendations to enhance digital performance throughout the customer journey. Its solutions enable clients to better understand user interactions, measure content effectiveness, and clarify consumer intentions, ultimately leading to increased revenue and engagement while reducing operational costs. ContentSquare serves over 700 enterprise clients, including notable brands like American Express, Best Buy, and LVMH.

Kustomer

Series C in 2019
Founded in 2015, Kustomer develops a SaaS CRM platform for enterprise-level customer service. Its platform unifies data from multiple sources, enabling companies to deliver service through a single timeline view. It serves leading brands such as Ring and Glossier.

Bellhops

Series C in 2018
Bellhops, Inc. is a U.S. moving services company that provides loading and unloading for trucks, trailers, storage units, and mobile storage containers, along with heavy lifting. It operates via an online platform and mobile applications that connect customers with movers, enabling local and short- to mid-distance moves for households and businesses. The company emphasizes a technology-enabled model to improve customer experience and pricing transparency, offering booking through a self-service dashboard and a team of movers. Founded in 2013 and based in Chattanooga, Tennessee, Bellhops serves customers across numerous U.S. cities, focusing on small and medium-scale moves and expanding its geographic footprint.

Antiva Biosciences

Series C in 2018
Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

Rocketrip

Series C in 2018
Rocketrip, Inc. is a travel management platform founded in 2013 and based in New York, New York. The company focuses on enabling employees to make cost-effective travel decisions while earning rewards for saving on expenses. Its platform provides real-time insights into reasonable travel spending, allowing users to compare costs and choose lower-priced options for flights, cars, and hotels without disrupting their online booking process. By establishing a custom-calibrated budget known as the Price to Beat, Rocketrip incentivizes employees to select economical travel arrangements, thereby promoting a culture of cost savings within organizations. The platform is utilized by several enterprise brands, demonstrating its effectiveness in the corporate travel sector. As of September 2020, Rocketrip operates as a subsidiary of Mondee Holdings Inc.

Arvinas

Series C in 2018
Arvinas, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, that specializes in the discovery, development, and commercialization of innovative therapies aimed at degrading disease-causing proteins. The company's lead product candidates include ARV-110, a proteolysis targeting chimera (PROTAC) currently in phase I clinical trials for metastatic castration-resistant prostate cancer, and ARV-471, which targets the estrogen receptor for patients with metastatic ER-positive/HER2-negative breast cancer. In addition to these, Arvinas is developing various other PROTACs aimed at degrading clinically relevant androgen receptor mutations and treatments for neurodegenerative diseases, including tauopathies. The company has established collaborations with prominent pharmaceutical firms such as Pfizer Inc., Genentech, and Bayer AG, enhancing its research capabilities and reach within the biopharmaceutical landscape. Founded in 2015, Arvinas aims to improve patient outcomes by eliminating harmful proteins from the body through its proprietary technology.

Apartment List

Series C in 2018
Apartment List is an online rental marketplace in the United States that connects renters with landlords. The platform offers a search experience with details on prices, locations, and amenities through web and mobile interfaces. The company emphasizes a fair, transparent, and simple renting process and provides a personalized search that learns user preferences to streamline finding suitable apartments. Based in San Francisco, it serves tenants and property owners by helping users discover listings and make informed decisions, reducing time and hassle in the search. Established in the late 2000s, Apartment List aims to make the home-finding process more personal, flexible, and efficient.

UrbanSitter

Series C in 2017
Founded in 2010, UrbanSitter operates a childcare marketplace that connects parents with trusted babysitters and nannies recommended by people within their network. The platform also offers services for pet sitting, housekeeping, tutoring, and senior care. With a focus on convenience and reliability, UrbanSitter enables users to book caregivers at short notice.

Unchained Labs

Series C in 2017
Unchained Labs is a life sciences tools company based in Pleasanton, California, specializing in solutions for biologics and gene therapy researchers. Established in 2014, it develops a range of products designed to enhance the efficiency and effectiveness of research in protein stability and formulation. Key offerings include the Optim platform, which allows researchers to measure multiple protein stability parameters simultaneously, and GRUNT, an automated system for biologic formulation preparation. In addition to these, the company provides various tools such as protein sizing systems, stability quantifiers, and automated buffer exchange systems. Unchained Labs serves biopharma and academic customers globally, distributing its products through partnerships in Europe, North and South America, Japan, and other Asian markets.

Glooko

Series C in 2017
Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

Antiva Biosciences

Series C in 2017
Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

Leanplum

Series C in 2016
Leanplum Inc. is a mobile marketing platform that specializes in enhancing engagement for brands through a unified, multichannel approach. Founded in 2012 and headquartered in San Francisco, with additional offices in New York, London, Bulgaria, and Amsterdam, Leanplum enables businesses to optimize their mobile applications and marketing efforts. The platform offers a range of services including messaging, automation, app editing, personalization, A/B testing, and analytics, allowing product teams to conduct real-time optimization tests and analyze results effectively. Renowned global brands such as Tinder, Grab, Tesco, and Zynga utilize Leanplum to orchestrate integrated campaigns that foster customer loyalty and drive growth. By transforming data into actionable insights, Leanplum helps companies understand user needs, delivering relevant experiences that enhance brand engagement and establish long-term customer relationships.

Glooko

Series C in 2016
Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

Sample6

Series C in 2016
Sample6 is a biotechnology company that specializes in the development of a synthetic-biology based diagnostic system for bacteria. Its innovative technology enables enrichment-free detection of harmful bacteria, identifying levels as low as 1 CFU/ml within just four hours. The proprietary Bioillumination Platform, created by a team of researchers including Professor Tim Lu from MIT, allows for the engineering of bioparticles that target specific unwanted bacteria, illuminating them for detection. This system is coupled with sensitive sensor technology that provides rapid on-site results without the need for a laboratory. Sample6 aims to enhance public health and safety by enabling quick and efficient detection of harmful bacteria across various industries, including food production, retail, and healthcare, addressing environments where humans and bacteria interact.

Minimally invasive devices

Series C in 2015
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.

CircleUp

Series C in 2015
CircleUp is a San Francisco-based company established in 2012, operating an online platform that connects early-stage consumer and retail brands with accredited investors. The platform facilitates capital raising and provides resources to these companies, enabling them to grow and scale. CircleUp's proprietary machine learning platform, Helio, evaluates and predicts the potential success of over 1.3 million consumer businesses, aiding in the discovery and selection of promising investment opportunities.

Protagonist Therapeutics

Series C in 2015
Protagonist Therapeutics, Inc., established in 2006 and headquartered in Newark, California, is a clinical-stage biopharmaceutical company focused on developing peptide-based therapies to address unmet medical needs in hematology and gastroenterology. The company's pipeline includes PTG-300, an injectable hepcidin mimetic in Phase II trials for beta-thalassemia; PTG-200, a completed Phase I antagonist peptide candidate for moderate-to-severe Crohn’s disease; and PN-943, an oral integrin antagonist in Phase I trials for inflammatory bowel disease. Protagonist has a licensing and collaboration agreement with Janssen Biotech for PTG-200's development and commercialization. The company's proprietary platform enables the discovery of novel constrained peptide-based drug candidates targeting protein-protein interactions.

NatureBox

Series C in 2015
NatureBox is a California-based company established in 2011, specializing in the delivery of healthier snack options directly to consumers' doors. It offers a variety of non-GMO and vegan snacks such as dried fruits, nut mixes, cookies, bars, chips, crackers, and popcorn, catering to diverse dietary preferences. NatureBox operates an online platform that allows users to personalize their orders based on taste and dietary needs. With a customer base growing at a rate of 50-100% monthly, the company serves customers across all 50 states. In addition to its commercial operations, NatureBox is committed to social responsibility, partnering with WhyHunger to provide nutritious food to those in need and previously donating over 150,000 meals to Feeding America.

Naaptol Online Shopping

Series C in 2015
Naaptol Online Shopping operates an e-commerce platform that offers a broad range of daily lifestyle products, including electronics, home goods, fashion accessories, gifts, and other consumer items, enabling customers to shop online and have purchases delivered to their doorstep.

CytomX Therapeutics

Series C in 2015
CytomX Therapeutics is a clinical-stage oncology-focused biopharmaceutical company that develops proteolytically-activated antibodies based on its Probody technology platform. Probody therapeutics are designed to be activated by the tumor microenvironment, enabling targeted cancer immunotherapies with reduced activity in healthy tissues. The company advances antibody and antibody-drug conjugate programs such as CX-072 (PD-L1), CX-2009 (CD166-targeted PDC), BMS-986249 (CTLA-4 Probody), CX-2029 (CD71-targeted PDC), and BMS-986288 (CTLA-4 Probody) in clinical research, and maintains collaborations with AbbVie, Amgen, Bristol-Myers Squibb, ImmunoGen, Pfizer, and Astellas to develop Probody therapeutics. Founded in 2008 and headquartered in South San Francisco, the company aims to improve the precision and safety of antibody-based therapies for cancer and inflammatory diseases.

Civitas Therapeutics

Series C in 2014
Civitas Therapeutics is a biopharmaceutical company dedicated to the development and commercialization of innovative pulmonary delivery therapies aimed at treating central nervous system and respiratory disorders. Utilizing its proprietary ARCUS technology, Civitas aims to transform the therapeutic landscape for patients across the United States. The company's focus is on creating effective treatments that enhance patient outcomes and address unmet medical needs in these critical areas.

Dermira

Series C in 2014
Dermira, Inc. is a biopharmaceutical company that specializes in developing and commercializing therapies for dermatologic diseases, primarily targeting the U.S. market. Founded in 2010 and headquartered in Menlo Park, California, Dermira offers QBREXZA, a topical treatment for primary axillary hyperhidrosis in patients aged nine and older. The company is also advancing its pipeline with lebrikizumab, a monoclonal antibody currently in Phase IIb trials for moderate-to-severe atopic dermatitis, alongside several other early-stage research initiatives in dermatology. Dermira has established strategic partnerships for the development and commercialization of its products, including agreements with Maruho Co., Ltd., F. Hoffmann-La Roche Ltd, Genentech, Inc., and UCB Pharma S.A. Notably, Dermira was previously known as Skintelligence, Inc. before rebranding in September 2011. As of early 2020, Dermira operates as a subsidiary of Eli Lilly and Company.

Truveris

Series C in 2014
Truveris is a health information technology company based in New York that focuses on bringing transparency to the prescription drug ecosystem. Founded in 2009, Truveris develops management tools for sponsors and payers of claims under prescription benefit plans. Its platform offers data-driven insights to help customers, including patients, employers, retailers, pharmacy benefits stakeholders, and manufacturers, manage rising costs and market access challenges effectively. The company's solutions include RxChoice, TruBid, and RxDash, which serve various entities in the pharmacy value chain.

The RealReal

Series C in 2014
The RealReal operates an online marketplace for authenticated luxury resale, offering fashion for women, men and kids, as well as jewelry, watches, art and home items. Founded in 2011 and headquartered in San Francisco, it functions as a full-service consignment platform that authenticates every item through in-house experts and uses technology to determine pricing, while managing photography, listings, payments and shipping. It is the largest pure-play luxury resale platform in the United States and supports a sustainable circular economy by facilitating resale across multiple categories. The company generates revenue primarily from consignments and first-party sales on its marketplace, with additional direct sales, and provides services such as virtual appointments, in-home pickup and direct shipping to buyers.

ShopKeep

Series C in 2014
ShopKeep is a New York-based company that provides comprehensive point of sale (POS) solutions for small and medium-sized businesses. Founded in 2008, ShopKeep offers hardware such as card readers, receipt printers, and cash drawers, along with cloud-based software for inventory management, employee tracking, customer analytics, and reporting. Its POS system runs on an iPad, supporting EMV and NFC for secure payments including Apple Pay. Additionally, ShopKeep provides merchant cash advance services, marketing tools, and integrations with third-party software providers like accounting and loyalty programs. With over 25,000 customers across the U.S., Canada, and Guam, ShopKeep's award-winning customer support is available 24/7 to assist businesses in running smarter operations.

SilverRail

Series C in 2014
SilverRail, established in 2009 and headquartered in London, UK, specializes in digital infrastructure for the rail industry. Its platform connects rail carriers and suppliers with travel distributors, offering a comprehensive customer experience from journey planning to ticketing. This includes inventory management, scheduling, pricing, booking, payment, and administration, facilitating seamless global rail access.

Spinifex Pharmaceuticals

Series C in 2014
Spinifex is backed by a syndicate of experienced life science investors including Novo Ventures, Canaan Partners, GBS Venture Partners, Brandon Capital Partners, Uniseed and UniQuest. Founded in 2005, Spinifex raised an initial AU$3.25 million in Series A fundraising and a total of AU$23.08 in Series B funding support the further development of EMA401. Spinifex raised a US$45 million in a Series C round led by Novo Ventures and including additional new investor Canaan Partners in 2014. Spinifex has a strong portfolio of intellectual property around its lead compound EMA01, follow on candidates and the use of AT2 receptor antagonists to treat both neuropathic & inflammatory pain and restore nerve conduction velocity deficits, including granted US, European, Japanese, Chinese, Australian and New Zealand patents.

Transcend Medical

Series C in 2014
Transcend Medical, Inc. is an ophthalmic device company based in Menlo Park, California, focused on developing innovative medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005, Transcend Medical emerged from ForSight Labs, an incubator dedicated to ophthalmic innovations. The company's flagship product, the CyPass Micro-Stent, is a micro-invasive device designed to be implanted during routine cataract surgery to reduce intraocular pressure. Additionally, Transcend Medical offers the Vold Gonio Lens for use in micro-invasive glaucoma surgeries and provides clinical trial services. The CyPass Micro-Stent received its CE mark in 2008 and has been undergoing evaluation in various clinical studies, including the COMPASS multi-center trial, to assess its effectiveness and safety in treating glaucoma. As of 2016, Transcend Medical operates as a subsidiary of Alcon Holdings, Inc.

Marinus Pharmaceuticals

Series C in 2013
Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for rare seizure disorders and neuropsychiatric conditions. The company's lead product candidate, ganaxolone, functions as an allosteric modulator of GABAA receptors and is being developed in both intravenous and oral formulations for use in various patient populations, including adults and children. Ganaxolone is targeted for multiple indications, such as status epilepticus, cyclin dependent kinase like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, postpartum depression, and treatment-resistant depression. Marinus Pharmaceuticals emphasizes collaboration with healthcare professionals and partners to enhance patient care and improve the lives of those affected by these conditions. Founded in 2003 and headquartered in Radnor, Pennsylvania, the company is committed to advancing its therapeutic offerings through rigorous scientific research and development.

Switchfly

Series C in 2012
Switchfly is a travel eCommerce platform that focuses on enhancing the booking and management experience for airlines, hotels, and financial services companies. The company specializes in dynamic packaging, which allows clients to create tailored travel experiences by integrating various services, including flights, hotel accommodations, car rentals, and customer support. By offering a comprehensive rewards and recognition platform, Switchfly aims to connect different travel partners into a cohesive system that improves customer engagement and maximizes conversion rates. Its technology facilitates seamless interactions, enabling organizations to provide a more efficient and user-friendly travel experience for their clients.

Borro Private Finance

Series C in 2012
Borro Private Finance is an online lending company that specializes in providing loans secured against luxury assets such as fine art, classic cars, jewelry, and watches. Founded in 2008 and headquartered in London, with an additional office in New York, the company offers discreet financing options that allow individuals to leverage their high-value possessions as collateral for both short and long-term loans. Borro's in-house valuation expertise ensures clients receive accurate assessments of their assets, facilitating quick access to capital for various needs, whether to capitalize on opportunities or manage unexpected expenses. The company operates as a subsidiary of Luxury Asset Capital LLC.

Terra Bella

Series C in 2012
Terra Bella is a private company based in Mountain View, California, specializing in high-resolution satellite imagery and analytics services. Originally founded as Skybox Imaging in 2009 by Dan Berkenstock, Julian Mann, John Fenwick, and Ching-Yu Hu, the company operates the SkySat-1 satellite, which captures detailed panchromatic and multispectral images of the Earth. Terra Bella focuses on analyzing the movement of goods and people, providing valuable visual data for various applications, including supply chain monitoring, shipping logistics, industrial plant activity, and humanitarian relief efforts. Through its advanced imaging technology, the company aims to deliver critical insights that support decision-making across multiple sectors.

Switchfly

Series C in 2012
Switchfly is a travel eCommerce platform that focuses on enhancing the booking and management experience for airlines, hotels, and financial services companies. The company specializes in dynamic packaging, which allows clients to create tailored travel experiences by integrating various services, including flights, hotel accommodations, car rentals, and customer support. By offering a comprehensive rewards and recognition platform, Switchfly aims to connect different travel partners into a cohesive system that improves customer engagement and maximizes conversion rates. Its technology facilitates seamless interactions, enabling organizations to provide a more efficient and user-friendly travel experience for their clients.

OpenSky

Series C in 2011
OpenSky Inc. is a technology company focused on empowering small business entrepreneurs through innovative software, services, and data solutions. The company operates two primary businesses, Alibaba.com (USA) and MoreCommerce, facilitating trade for hundreds of thousands of businesses that collectively handle billions of dollars in goods annually. OpenSky aims to make commerce more instantaneous, open, and connected by providing a business-to-business trading platform that features a diverse range of products, including electronics, health and beauty items, and home goods. Recognized for its innovative approach, OpenSky has received accolades from various industry sources, highlighting its commitment to transforming global trade through user-friendly technology.

CarTrade

Series C in 2011
CarTrade is India's leading online automotive marketplace for buying and selling new and used vehicles. It facilitates car auctions across over 80 cities with participation from more than 1200 dealers, enabling buyers and sellers to find suitable options at affordable prices.

Kabam

Series C in 2011
Kabam is an entertainment company that specializes in developing free-to-play games for mobile devices and web platforms. Founded in 2006 and rebranded in 2010, the company is headquartered in San Francisco, California, with additional offices in Los Angeles, Vancouver, Austin, Beijing, London, and Berlin. Kabam offers a diverse portfolio of games, including traditional, social, strategy, action, arcade, sports, and role-playing genres. The company emphasizes the integration of traditional and social gaming elements to create engaging multiplayer experiences, allowing players to enjoy real-time interactions and enhanced gameplay with their friends.

LiveU

Series C in 2010
LiveU specializes in real-time video streaming solutions for global broadcasters, enabling reliable live video acquisition and distribution across various platforms. Its product portfolio includes field units, encoders, software, decoders, and digital products, catering to diverse industries such as news agencies, sports channels, and online publishers.

Cardlytics

Series C in 2010
Cardlytics operates an advertising platform within financial institutions' digital channels, enabling marketers to reach consumers through trusted online and mobile banking channels. It uses purchase-based intelligence to make marketing more relevant and measurable, partnering with over 1,500 financial institutions worldwide.

Liquidia Technologies

Series C in 2010
Liquidia Technologies is a late-stage clinical biopharmaceutical company based in the United States, dedicated to developing and commercializing innovative therapeutics. Utilizing its proprietary PRINT technology, a particle engineering platform, Liquidia produces uniform drug particles aimed at enhancing the safety and efficacy of various therapies. The company is advancing two key product candidates: LIQ861, intended for the treatment of pulmonary arterial hypertension, and LIQ865, designed for managing local post-operative pain. Additionally, Liquidia collaborates with leading pharmaceutical firms to leverage its PRINT technology across multiple therapeutic areas, molecule types, and administration routes, addressing unmet patient needs, particularly in the realm of pulmonary hypertension.

Blip

Series C in 2010
Blip is an online media platform that offers users access to a variety of video clips and programs focused on media and entertainment. The platform features content across multiple categories, including general entertainment, comedy, music, drama, television, food, and video games. It organizes its offerings into segments such as editors' picks, current trends, and new episodes. Additionally, Blip provides producers with tools to host, distribute, and monetize their web series. Founded in 2005 by Charles Hope and Jared Klett, Blip is headquartered in New York City.

Lending Club

Series C in 2010
LendingClub Corporation is an online lending marketplace based in San Francisco, California, that connects creditworthy borrowers with investors. Founded in 2006, the platform offers a variety of unsecured personal loan products, including options for education, patient finance, auto refinancing, and small business loans. By facilitating direct investment in these loans, LendingClub provides investors access to an asset class that has traditionally been limited to institutional investors. The company generates most of its revenue through transaction fees from its role in processing loan applications and working with bank partners to enable loan originations. This approach aims to simplify and accelerate the lending process, making it more accessible for consumers and beneficial for investors.

Vivox

Series C in 2010
Vivox, Inc. is a communication technology company based in Natick, Massachusetts, specializing in voice and messaging applications tailored for online gaming and social networking environments. Founded in 2003, Vivox provides an integrated voice platform that allows users to communicate seamlessly while engaging in games or social interactions. Its flagship offerings include C3, which grants control and access for publishers and studios, and Integrated Voice, facilitating real-time communication among players. The company partners with game and social publishers to enhance user engagement through voice services, while also generating revenue through audio advertisements and virtual goods. With over 45 million users across more than 200 countries, Vivox enables the exchange of over three billion voice chat minutes monthly, fostering natural and immersive interactions in digital spaces. Vivox operates as a subsidiary of Unity Technologies, enhancing its reach and capabilities in the gaming industry.

Liquidia Technologies

Series C in 2010
Liquidia Technologies is a late-stage clinical biopharmaceutical company based in the United States, dedicated to developing and commercializing innovative therapeutics. Utilizing its proprietary PRINT technology, a particle engineering platform, Liquidia produces uniform drug particles aimed at enhancing the safety and efficacy of various therapies. The company is advancing two key product candidates: LIQ861, intended for the treatment of pulmonary arterial hypertension, and LIQ865, designed for managing local post-operative pain. Additionally, Liquidia collaborates with leading pharmaceutical firms to leverage its PRINT technology across multiple therapeutic areas, molecule types, and administration routes, addressing unmet patient needs, particularly in the realm of pulmonary hypertension.

iYogi

Series C in 2010
iYogi, Inc. is an on-demand software and services company that specializes in providing online technical support for various computing and communication devices. Founded in 2007 and headquartered in Gurugram, India, iYogi offers a range of services including optimization, diagnosis and repair, setup and installation, virus removal, usability training, networking, and managed services. The company caters to both consumers and small businesses, supporting a wide array of software applications and hardware, including computers, mobiles, gaming devices, and servers. With a focus on convenience, iYogi delivers subscription-based support that allows clients to optimize and secure their technology with 24/7 access to technicians. Its services reach customers in several countries, including the United States, the United Kingdom, Canada, Australia, India, and the GCC states.

SOASTA

Series C in 2009
SOASTA, Inc. is a performance analytics platform that specializes in cloud testing and monitoring solutions for web and mobile applications. Founded in 2006 and headquartered in Mountain View, California, the company provides comprehensive tools that help digital businesses analyze and optimize their performance in real-time. Its offerings include mPulse, a real user monitoring solution that correlates performance with business outcomes; CloudTest, a platform for load and performance testing; TouchTest, which focuses on mobile functional test automation; and the Digital Operations Center, which delivers insights into performance metrics. SOASTA has conducted over 10 million tests and measured more than 100 billion user experiences, serving a range of industry-leading clients. The company also offers a variety of support services, including testing consultation, training, and development assistance, ensuring that clients can effectively manage their digital performance strategies. As of 2017, SOASTA operates as a subsidiary of Akamai Technologies.

Relievant Medsystems

Series C in 2009
Relievant Medsystems, Inc. is a medical device company focused on developing innovative solutions for chronic axial low back pain. Founded in 2004 and headquartered in Minneapolis, Minnesota, with a development office in Sunnyvale, California, the company has created the Intracept System. This minimally invasive procedure specifically targets the basivertebral nerve, providing relief by blocking pain signal transmission. The Intracept System offers patients a low-risk therapy option aimed at alleviating chronic vertebrogenic low back pain.

Zoosk

Series C in 2009
Zoosk, Inc. is a prominent online dating platform founded in 2007 and headquartered in San Francisco, California. The company operates a dating website and mobile applications for iPhone and Android, utilizing its proprietary Behavioral Matchmaking™ technology to enhance user experience by learning from the interactions of over 27 million active members. This technology allows Zoosk to provide real-time match suggestions based on user behavior, helping individuals find compatible partners. Available in over 80 countries and translated into 25 languages, Zoosk caters to a diverse audience aged 18 and older. The platform not only facilitates connections between singles but also offers relationship and dating advice to support users in their pursuit of meaningful relationships. In 2019, Zoosk became a subsidiary of Spark Networks SE.

Peer39

Series C in 2009
Peer39 Tech, LLC is a New York-based company that specializes in AI-powered contextual targeting and fraud detection tools for digital advertising. Founded in 2006, the company has developed a platform that employs natural language processing and machine learning to perform comprehensive analyses of web pages, facilitating page-level intelligence for advertisers. Peer39 offers a suite of services, including intelligent page-level analysis, keyword suggestion engines, and custom category automation, which help brands find relevant contexts for their media investments. Additionally, the platform features advanced fraud detection capabilities and metrics to filter out invalid traffic, ensuring the integrity of advertising campaigns. By providing a comprehensive library of pre-bid contextual categories, Peer39 supports advertisers in delivering targeted and safe messages to their audiences, positioning itself as a leader in the non-cookie based data space within the digital media landscape.

Associated Content

Series C in 2009
Associated Content was a Denver-based platform that enabled users to create and publish content in various formats (text, video, audio, images) across diverse topics. The platform connected this user-generated content with consumers, partners, and advertisers, attracting millions of monthly viewers. In 2010, it was acquired by Yahoo.

Tremor Video

Series C in 2009
Provides video advertising solutions for advertisers and agencies, and publisher partners in the United States and internationally.

Telaria

Series C in 2009
Telaria is a software platform that enables publishers worldwide to manage and monetize their digital video inventory. It offers real-time analytics, data-driven decisioning tools, and optimization solutions for publishers' ad yield.

Motionbox

Series C in 2009
Motionbox is a video sharing service that offers a range of features designed to enhance the user experience in video editing and sharing. Users can upload full video files, which the platform transcodes to reduce file size while retaining the original files for download or DVD purchase. Motionbox's editing capabilities allow users to manipulate videos extensively, including linking multiple files and creating mashups with public or shared videos. The service supports deep tagging, enabling users to tag specific portions of their videos for easier navigation. Since March 2008, Motionbox has supported high-definition video, and it offers a subscription-based Premium service that includes HD playback, unlimited storage, and download options. Additionally, it provides a Professional video hosting solution tailored for small businesses and organizations.

BiPar Sciences

Series C in 2009
BiPar Sciences Inc. is a biotechnology company based in Brisbane, California, focused on developing innovative cancer therapies, particularly through the use of PARP inhibitors. Its lead product, BSI-201, is currently undergoing mid-stage clinical trials for advanced breast cancer, ovarian cancer, and other challenging tumors. BiPar's portfolio also includes candidates targeting therapy-resistant cancers and additional drug programs aimed at enhancing the efficacy of chemotherapy. The company has secured approximately $60 million in venture capital funding from various investors and has attracted venture debt to support its initiatives. In April 2009, BiPar Sciences was acquired by the French pharmaceutical company Sanofi-Aventis, indicating its potential significance in the oncology market.

Blurb

Series C in 2008
Blurb, Inc. operates a self-publishing and marketing platform that allows users to create and publish a variety of books and magazines in both print and digital formats. Founded in 2005 and headquartered in San Francisco with an additional office in London, the company offers tools such as an Adobe InDesign plug-in and BookWright, enabling users to design and layout books, photo books, and magazines. Blurb caters to a diverse range of publishing needs, including trade books, photography, memoirs, and personalized keepsakes. Authors can utilize Blurb's platform to sell their works directly through their own websites or social media, with the company managing the printing and shipping of orders. Blurb is recognized for its focus on high-quality coffee table books and fixed-format ebooks, making it a popular choice for both professional and amateur creators. As of August 2020, Blurb operates as a subsidiary of Reischling Press, Inc.

CoAxia

Series C in 2008
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of innovative therapies and treatment solutions for cerebral ischemia. The company focuses on creating devices that control blood flow to the brain, specifically through its neuroflo and flocontrol products. These devices are designed to divert blood flow in patients, thereby helping to reduce the risk of strokes and heart attacks, particularly in individuals experiencing vasospasm and heart blockage. CoAxia aims to improve patient outcomes by providing advanced medical solutions for critical conditions related to cerebral blood flow.

Xirrus

Series C in 2008
Xirrus, Inc., established in 2004 and headquartered in Thousand Oaks, California, specializes in wireless access network solutions. It offers a range of products including high-density and outdoor access points, wired switches, network accessories like enclosures and mountings, and power options. Xirrus also provides software solutions such as the Xirrus Management System for network deployment and management, EasyPass Personal Wi-Fi for secure public Wi-Fi access, Wi-Fi Designer for predictive heat-map network design, and XA4 for high-density user experiences in large venues. Serving clients across enterprise, education, healthcare, hospitality, and other markets both domestically and internationally, Xirrus operates as a subsidiary of Riverbed Technology, Inc., focusing on delivering robust wireless networking solutions.

N-trig

Series C in 2008
N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

PicksPal

Series C in 2007
PicksPal.com allows its users to compete daily in 'pick em games with points made available to them upon registering. The games vary from whether an NBA team will cover the spread on opening night to who will score first in the college football game of your choice this weekend. While the site is free and ad-supported, users can purchase pick packages from the site's best pickers through the "Genius Picks" service. Other sports sites like [YouBeQB!](http://www.crunchbase.com/organization/youbeqb) also provide fans with a new take on the fantasy sports/roto league competition model.

Pavad Medical

Series C in 2007
PAVAD Medical, Inc., a medical device startup company, develops therapeutic technologies in the areas of obstructive sleep apnea. The company was incorporated in 2002 and is based in Fremont, California.

Apieron

Series C in 2007
Apieron is a medical technology company that specializes in developing non-invasive monitoring devices for asthma management. The company's flagship product measures exhaled nitric oxide (eNO), a biomarker associated with airway inflammation, providing valuable insights for the management of asthmatic conditions. Currently, Apieron's device has received clearance from the FDA but is restricted for use within a physician's office setting. By offering a reliable method for tracking asthma-related metrics, Apieron aims to enhance patient care and support healthcare providers in effectively managing respiratory health.

ID Analytics

Series C in 2007
ID Analytics, Inc. is a provider of identity risk and fraud management solutions based in San Diego, California. Founded in 2002, the company specializes in offering a range of services that deliver on-demand identity intelligence across various customer interaction points, such as online platforms, call centers, and in-store engagements. Its key offerings include ID Score-Risk, which assesses identity risk, ID Score-Action, which generates an identity risk score, and ID Score-Revenue, which supports customer management decisions aimed at enhancing revenue and improving customer experiences. Additionally, ID Analytics provides solutions for regulatory compliance and data defense, addressing issues related to the organized misuse of personal information. The company serves a diverse array of industries, including communications, financial services, retail, insurance, e-commerce, and government sectors.

Transoma Medical

Series C in 2007
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.

Viracor-IBT Laboratories

Series C in 2007
Viracor-IBT Laboratories is dedicated to being the leading specialty diagnostics laboratory partner in allergy, immunology, and infectious disease testing. They provide doctors and hospitals the tests, results and support they need to deliver the best care possible, and they collaborate with pharmaceutical researchers to solve difficult problems and accelerate drug development.

Advanced BioHealing

Series C in 2007
Advanced BioHealing is an industry leader in the science of regenerative medicine. The Company is focused on the commercialization of cell-based and tissue-engineered products. It currently markets the FDA-approved product Dermagraft®, for diabetic foot ulcers. Additionally, the Company's development pipeline includes a next-generation bioengineered tissue product which is in clinical trials. ABH is a privately held company with research & development offices in New York, NY and manufacturing operations in La Jolla, CA.

GroundWork

Series C in 2007
GroundWork Inc. is a provider of unified monitoring solutions tailored for IT operations management and cloud environments. Established in 2004 and headquartered in San Francisco, the company designs and develops software that facilitates the monitoring of physical, virtual, and cloud-based infrastructures. GroundWork’s open platform supports easy integrations and customized visualizations, enabling organizations to oversee a wide range of components, including networks, applications, servers, and storage data. The company’s offerings include tools for operations analysis, automation, and performance monitoring, which are crucial for maintaining the security and scalability of IT environments. GroundWork caters to various industries, such as aerospace, life sciences, manufacturing, and telecommunications, serving clients who require comprehensive visibility and control over their IT operations.

VaxInnate

Series C in 2006
VaxInnate is a vaccine company founded in 2002 and headquartered in Cranbury, New Jersey, that specializes in developing vaccines for various infectious diseases, including flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. The company utilizes a unique technology that involves genetically fusing vaccine antigens to the bacterial protein flagellin, enhancing the immunogenicity and efficacy of its vaccines. This innovative approach allows for quicker treatment initiation, increasing the likelihood of successful patient outcomes. VaxInnate operates within the healthcare, health diagnostics, and biotechnology sectors, focusing on advancing vaccine development to address significant global health challenges.

CoAxia

Series C in 2006
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of innovative therapies and treatment solutions for cerebral ischemia. The company focuses on creating devices that control blood flow to the brain, specifically through its neuroflo and flocontrol products. These devices are designed to divert blood flow in patients, thereby helping to reduce the risk of strokes and heart attacks, particularly in individuals experiencing vasospasm and heart blockage. CoAxia aims to improve patient outcomes by providing advanced medical solutions for critical conditions related to cerebral blood flow.

Enpirion

Series C in 2006
Enpirion is a manufacturer specializing in integrated power management chipsets, particularly known for its innovative line of Switch-mode DC-DC converters that incorporate an integrated inductor. This design minimizes issues related to power integrated circuit failures, reduces footprint and part count, and lowers noise in power conversion processes. Enpirion's products cater to a variety of applications, including high-volume consumer electronics such as mobile phones, portable gaming devices, and personal media players, as well as in sectors like data networking, telecommunications, and computing. The company's focus on high-frequency, high-efficiency voltage conversion solutions enables businesses to meet stringent power requirements while enhancing the performance and stability of their electronic systems.

ReVision Optics

Series C in 2006
ReVision Optics, Inc. is a company that specializes in designing, manufacturing, and delivering implantable products aimed at treating presbyopia, a condition associated with the natural aging process that affects near vision. The company's flagship product, the PRESBYLENS Corneal Inlay, offers a patented refractive surgery solution that enhances visual acuity for individuals experiencing age-related vision loss. Founded in 1996 and based in Lake Forest, California, ReVision Optics serves ophthalmology professionals, providing them with advanced technology to improve patient outcomes. Originally established as IntraLens Vision, Inc., the company rebranded to its current name in 2005, reflecting its focus on innovative optical solutions.

Qovia

Series C in 2006
Qovia is a company that specializes in voice over Internet Protocol (VoIP) telephony monitoring and management technologies. Founded in 2002 and based in Frederick, Maryland, Qovia develops software products designed to monitor and manage voice quality on VoIP telephone systems. Its solutions cater to a diverse range of customers, including school districts, government agencies, law enforcement, banking and financial institutions, call centers, and voice carriers. By leveraging internet technology to enhance voice communication, Qovia positions itself at the forefront of next-generation phone systems.

Spine Wave

Series C in 2006
Spine Wave, Inc. is a medical device company that specializes in the development and marketing of innovative solutions for spinal disorders. Founded in 2001 and based in Shelton, Connecticut, the company offers a diverse range of products including expandable PEEK spacers, interbody devices for posterior surgery, and lateral stabilization systems. Its offerings also encompass the GraftMag Graft Delivery System for large bone graft delivery, fixation products for treating thoracolumbar spine conditions, and anterior cervical plate systems for spinal fusion. Spine Wave prioritizes a surgeon-driven product development approach, enabling it to create a differentiated portfolio of less invasive and efficient surgical solutions aimed at restoring spinal function and improving patients' quality of life. The company's products are distributed through various channels, ensuring wide accessibility for spine surgeons and their patients.

ReVision Optics

Series C in 2005
ReVision Optics, Inc. is a company that specializes in designing, manufacturing, and delivering implantable products aimed at treating presbyopia, a condition associated with the natural aging process that affects near vision. The company's flagship product, the PRESBYLENS Corneal Inlay, offers a patented refractive surgery solution that enhances visual acuity for individuals experiencing age-related vision loss. Founded in 1996 and based in Lake Forest, California, ReVision Optics serves ophthalmology professionals, providing them with advanced technology to improve patient outcomes. Originally established as IntraLens Vision, Inc., the company rebranded to its current name in 2005, reflecting its focus on innovative optical solutions.

Amicus Therapeutics

Series C in 2005
Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering therapies for rare and orphan diseases. It specializes in oral pharmacological chaperones—small molecules that bind, stabilize, and enhance activity of misfolded enzymes—to treat lysosomal storage disorders such as Fabry and Pompe disease, and it explores combination approaches with enzyme replacement therapy. The company maintains a growing pipeline targeting additional lysosomal diseases, including Gaucher, and collaborates with academic and clinical partners to advance its programs. Amicus was founded in 2002 and is headquartered in Cranbury, New Jersey.

Dexterra

Series C in 2005
Dexterra is a mobile platform and application provider, with complete solutions to manage and optimize your mobile workforce. Dexterra Concert, its mobile platform provides and open standards-based development environment that supports applications running on all types of mobile devices, integrated with most common back-office systems, and deployed in numerous countries and languages around the world. Its portfolio of mobile applications support field service, scheduling, dispatch, mobile tracking, field sales, asset management and location-based services. Business leaders in a variety of industries depend on Dexterra to mobile their operations, such as ADP, Ikon, Parts Associates, Safelite Autoglass, Tennant, Virgin Media, Verizon and Vodafone.

Cortina Systems

Series C in 2005
Cortina Systems specializes in advanced communication solutions, focusing on high-speed analog-digital integration. They cater to Core, Metro, Access, and Enterprise market segments, offering products that enhance performance, density, and flexibility. By collaborating with customers to understand their system requirements, Cortina Systems facilitates faster time-to-market and increased revenue opportunities.

Zolo Technologies

Series C in 2005
Zolo Technologies, Inc. specializes in the design, development, manufacture, installation, and servicing of laser-based and multiplexed combustion monitoring systems. Founded in 1999 and based in Boulder, Colorado, the company serves various industrial sectors, including power generation, steel production, and petrochemical refining. Zolo Technologies offers tunable diode laser absorption spectroscopy instruments that measure vital constituents such as oxygen, carbon monoxide, carbon dioxide, and temperature in demanding combustion environments. Its product applications include steam methane reformers, ethylene cracking, electric arc furnaces, and glass furnaces. The company markets its innovative solutions under the ZoloBOSS, Zolographics, and SensAlign brand names, enabling clients to optimize processes and improve product quality through enhanced monitoring and diagnostics.

Tacit Networks

Series C in 2005
Tacit Networks, Inc. is a provider of wide area file services and network optimization solutions, catering primarily to branch offices and remote users. Established in 2000 and headquartered in South Plainfield, New Jersey, the company specializes in its IShared product line, which assists businesses in consolidating, accelerating, and managing information. Tacit Networks offers a range of services including file management, exchange, networking, web, and print services. Its products are available both directly to clients and through a network of integrated reseller partners. In 2006, Tacit Networks was acquired by Packeteer, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.